Washington D.C. – May 9, 2025 – The Trump administration initiated a series of significant actions impacting the structure and funding of national health institutions on May 9, 2025, marking a pivotal day for federal healthcare policy and research.
The moves included the abrupt termination of a key infection control advisory committee, substantial layoffs at the nation’s premier biomedical research agency, and the unveiling of a proposed federal budget for 2026 that signals deep cuts to healthcare programs.
Infection Control Body Dissolved
Among the most notable actions was the termination of the Healthcare Infection Control Practices Advisory Committee (HICPAC). HICPAC is a critical federal advisory committee responsible for developing national standards and guidelines for infection prevention in healthcare settings. These standards are widely used across the country to protect patients and healthcare workers from potentially deadly infections.
The dissolution of the committee was confirmed by four of its members, who stated that the Centers for Disease Control and Prevention (CDC) delivered the news of HICPAC’s termination. The reasons cited for the committee’s termination were not immediately made public in detail, though critics quickly raised concerns about the potential implications for national preparedness and response to healthcare-associated infections at a time when infection control remains a vital public health priority.
NIH Faces Further Layoffs
Adding to the day’s significant changes, the National Institutes of Health (NIH), the nation’s leading agency for biomedical research, announced further reductions in its workforce. The agency laid off an additional 250 employees. This follows previous staffing adjustments within the NIH.
The layoffs included a notable number within the National Cancer Institute (NCI), one of the NIH’s largest and most critical institutes, where 50 positions were eliminated. The NCI plays a central role in the nation’s efforts to understand, treat, and prevent cancer, funding extensive research across the country.
A spokesperson for the Department of Health and Human Services (HHS), the parent department for both NIH and CDC, indicated that these workforce reductions align with President Trump’s Executive Order specifically aimed at reducing bureaucracy across federal agencies. The HHS statement suggested the layoffs were part of an ongoing effort to streamline operations and improve efficiency, though details on which specific roles or types of positions were affected were not immediately available.
Concerns were voiced by some in the scientific and public health communities regarding the potential impact of these layoffs on ongoing research initiatives and the capacity of the NIH and NCI to continue their work effectively, particularly in areas requiring long-term projects and specialized expertise.
Proposed 2026 Budget Signals Deep Cuts
Compounding the actions taken earlier in the day, the White House also released its proposed budget for the fiscal year 2026 on May 9, 2025. The budget proposal outlines significant cuts to various federal programs, with healthcare programs targeted for notable reductions.
While the full details of the extensive budget document require thorough review, initial analyses highlighted substantial proposed decreases in funding, particularly within the CDC and NIH. These proposals continue a discernible trend observed in previous administration budgets, which have sought to reduce overall federal spending on biomedical research and public health initiatives.
Proposed budget cuts, especially to agencies like the CDC and NIH, could have far-reaching effects, potentially impacting funding for disease surveillance, vaccine development, research into chronic and infectious diseases, and public health infrastructure at the state and local levels. Budget proposals represent the administration’s priorities but require approval and negotiation with Congress, where they are likely to face scrutiny and potential opposition, particularly regarding reductions to popular or critical public health programs.
Broader Implications
The combined effect of dissolving a key infection control body, reducing staff at the nation’s primary research institution, and proposing significant budget cuts for the upcoming fiscal year signals a potential reshaping of the federal government’s role and investment in public health and biomedical science under the current administration. Observers suggest these actions reflect a strategy to decrease the size and scope of federal health agencies and shift responsibilities or reduce overall government expenditure in these areas.
While the administration frames these moves as necessary steps to reduce bureaucracy and control spending, public health advocates and researchers express concerns about the potential long-term consequences for the nation’s ability to prevent and respond to health threats, and to maintain its leading position in medical innovation.
The developments of May 9, 2025, set the stage for what is expected to be a contentious debate over federal health spending and priorities as the proposed 2026 budget moves through the congressional appropriations process.
